DrugPatentWatch Database Preview

Lansoprazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lansoprazole and what is the scope of lansoprazole freedom to operate?

Lansoprazole is the generic ingredient in seven branded drugs marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Breckenridge Pharm, Dr Reddys Labs Ltd, Inventia Hlthcare, Krka Tovarna Zdravil, Labs Liconsa, Lannett Co Inc, Mylan Pharms Inc, Natco Pharma Ltd, Perrigo R And D, Sandoz, Sun Pharm Inds Ltd, Teva Pharms, Wockhardt Ltd, Wockhardt Usa, Zydus Hlthcare, Takeda Pharms Usa, Glaxosmithkline Cons, Takeda Pharms Na, Ani Pharms Inc, Dexcel Pharma, Teva Pharms Usa, and Zydus Pharms Usa Inc, and is included in thirty-three NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Lansoprazole has thirty-six patent family members in sixteen countries.

There are fifty-six drug master file entries for lansoprazole. Eighty-four suppliers are listed for this compound.

Summary for lansoprazole

International Patents:	36
US Patents:	5
Tradenames:	7
Applicants:	24
NDAs:	33
Drug Master File Entries:	56
Suppliers / Packagers:	84
Bulk Api Vendors:	109
Clinical Trials:	131
Patent Applications:	6,828
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for lansoprazole
Drug Sales Revenues:	Drug sales revenues for lansoprazole
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for lansoprazole
DailyMed Link:	lansoprazole at DailyMed

Pharmacology for lansoprazole

Drug Class	Proton Pump Inhibitor
Mechanism of Action	Proton Pump Inhibitors
Physiological Effect	Inhibition Gastric Acid Secretion

Medical Subject Heading (MeSH) Categories for lansoprazole

Anti-Ulcer Agents

Proton Pump Inhibitors

Synonyms for lansoprazole

(+)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole

103577-45-3

1H-Benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-

1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-

2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole

2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole

2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole

2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole

2-({[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfinyl)benzimidazol e

2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methane}sulfinyl)-1H-1,3-benzodiazole

2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole

2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole;2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole

2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole

2-[[ [3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole

2-[[[3-methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinyl]methyl]-sulfinyl]1H-benzimidazole

2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole

2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]benzimidazole

2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole

2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]-methyl]sulfinyl]benzimidazole

2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole

2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole

2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole

2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole

2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole

2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl]methylsulfinyl]benzimidazole

2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole

2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzoimidazole

2-[[3-methyl-4-[2,2,2-tris(fluoranyl)ethoxy]pyridin-2-yl]methylsulfinyl]-1H-benzimidazole

2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzimidazole

2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-benzimidazole

2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)pyridin-2-ylmethanesulfinyl]-benzimidazole

2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl-methanesulfinyl]-1H-benzimidazole

2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethanesulfinyl]-1H-benzimidazole

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl}-1H-benzimidazole

577L453

A 65006

A-65006

A800764

AB0005100

AB00052388

AB00052388_18

AB00052388_19

AB00052388-17

AB2000063

ABT-006

AC-1233

AC1L1GX8

ACT03358

AG 1749

AG-1749

Agopton

AKOS005554811

AN-15125

API0005388

Aprazol

Bamalite

BBL029072

BC208317

BCP22331

BDBM47032

BDBM50070208

BG0232

BIDD:GT0006

Biuret Gr

Biuret reagent

Biuret Reagent Solution

Blason

BPBio1_001194

BRD-A49172652-001-05-7

BRD-A49172652-001-13-1

BRN 4333393

BSPBio_001084

BSPBio_001830

C-21097

C16H14F3N3O2S

CAS-103577-45-3

CC-29843

CCG-39952

CG-4801

CHEBI:6375

CHEMBL480

cid_3883

CL0035

Compraz

CPD000058469

CS-1847

CTK8F0500

D00355

Dakar

DB00448

DivK1c_000920

DSSTox_CID_3200

DSSTox_GSID_23200

DSSTox_RID_76922

DTXSID4023200

EBD14854

EU-0100709

F2173-0222

FT-0082011

FT-0610894

GP5308

GTPL7208

HMS1571G06

HMS1922M04

HMS2052F05

HMS2093M07

HMS2098G06

HMS2234B10

HMS3262M19

HMS3264E12

HMS3269D15

HMS3371E21

HMS3394F05

HMS3654J17

HMS3715G06

HMS502N22

HSDB 7204

HY-13662

I06-0018

IDI1_000920

Ilsatec

J-007154

KBio1_000920

KBio2_002060

KBio2_004628

KBio2_007196

KBio3_001330

KBioGR_001491

KBioSS_002060

Ketian

KS-00000VHO

KS-1075

L 8533

L0233

Lancid

Lanfast

Lanproton

LANSAPRAZOLE

Lansopep

Lansophed

Lansoprazol

Lansoprazol [INN-Spanish]

Lansoprazole (JP17/USP/INN)

Lansoprazole [USAN:BAN:INN]

Lansoprazole [USAN:USP:INN:BAN]

Lansoprazole for peak identification, European Pharmacopoeia (EP) Reference Standard

Lansoprazole, >=98% (TLC), powder

Lansoprazole, British Pharmacopoeia (BP) Reference Standard

Lansoprazole, European Pharmacopoeia (EP) Reference Standard

Lansoprazole, United States Pharmacopeia (USP) Reference Standard

Lansoprazole,(S)

Lansoprazolum

Lansoprazolum [INN-Latin]

Lansox

Lanston

Lanz

Lanzo

Lanzol

Lanzol-30

Lanzopral

Lanzor

Lanzul

Lapraz

Lasoprol

Limpidex

Lopac-L-8533

Lopac0_000709

LP00709

LS-33080

MCULE-8446262134

Mesactol

MFCD00866873

MJIHNNLFOKEZEW-UHFFFAOYSA-N

MLS-0003247.0001

MLS000069705

MLS000759405

MLS001074170

MLS001424235

MolPort-003-666-508

Monolitum

NC00411

NCGC00015615-01

NCGC00015615-02

NCGC00015615-03

NCGC00015615-04

NCGC00015615-05

NCGC00015615-06

NCGC00015615-07

NCGC00015615-08

NCGC00015615-09

NCGC00015615-10

NCGC00015615-11

NCGC00015615-12

NCGC00015615-14

NCGC00015615-15

NCGC00023826-03

NCGC00023826-04

NCGC00023826-05

NCGC00023826-06

NCGC00023826-07

NCGC00254925-01

NCGC00261394-01

NINDS_000920

NSC-758638

NSC-758710

NSC758638

NSC758710

Ogast

Ogastro

Opera_ID_1676

Opiren

Pharmakon1600-01503926

Pharmakon1600-01504282

Prestwick0_001072

Prestwick1_001072

Prestwick2_001072

Prestwick3_001072

Prevacid

Prevacid (TN)

Prevacid 24HR

Prevacid Delayed Release

Prevacid I.V

Prevacid I.V.

Prevacid Iv

Prevacid NapraPAC

Prevacid SoluTab

Prevacid;Prevacid NapraPAC;Prevacid SoluTab

PrevOnco

Prezal

Pro Ulco

Promp

Prosogan

PubChem16834

RT-013461

s1354

SAM001246544

SB19127

SBI-0050687.P003

SC-15158

SCHEMBL22365

SMR000058469

SPBio_000488

SPBio_002992

Spectrum_001580

SPECTRUM1503926

Spectrum2_000444

Spectrum3_000295

Spectrum4_000856

Spectrum5_001521

SR-01000000169

SR-01000000169-2

SR-01000000169-6

SR-01000000169-9

ST51015040

STK621169

Suprecid

SW197226-4

TAK 390MR

TAK-390MR

Takepron

TL8000155

Tox21_110184

Tox21_110184_1

Tox21_301023

Tox21_500709

Ulpax

Zoprol

Zoton

US Patents and Regulatory Information for lansoprazole

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms Usa	LANSOPRAZOLE	lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	208784-001	Sep 21, 2017	AB	RX	No	No
Takeda Pharms Na	PREVACID	lansoprazole	FOR SUSPENSION, DELAYED RELEASE;ORAL	021281-002	May 3, 2001		DISCN	No	No
Mylan Pharms Inc	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	090763-002	Nov 10, 2009	AB	RX	No	No
Perrigo R And D	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	202319-001	May 18, 2012		OTC	No	No
Ani Pharms Inc	LANSOPRAZOLE	lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	078730-001	Oct 15, 2010		DISCN	No	No

Expired US Patents for lansoprazole

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Takeda Pharms Usa	PREVACID	lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	021428-002	Aug 30, 2002
Takeda Pharms Usa	PREVACID	lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	021428-001	Aug 30, 2002
Takeda Pharms Na	PREVACID	lansoprazole	FOR SUSPENSION, DELAYED RELEASE;ORAL	021281-001	May 3, 2001
Takeda Pharms Usa	PREVACID	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	020406-002	May 10, 1995
Takeda Pharms Usa	PREVACID	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	020406-002	May 10, 1995

International Patents for lansoprazole

Country	Patent Number	Estimated Expiration
Spain	2274625
Japan	2000281564
South Korea	20050010070
Portugal	1121103
Australia	7875501

Supplementary Protection Certificates for lansoprazole

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1129088	2014/008	Ireland		PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
0328535	96C0021	Belgium		PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
0174726	93C0021	Belgium		PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211